Caption Management, LLC Theravance Biopharma, Inc. Transaction History

Caption Management, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$9.65 - $11.34 $212,300 - $249,480	22,000 Added 36.67%	82,000 $920,000
Q3 2022 Nov 14, 2022	BUY	$8.39 - $10.22 $503,400 - $613,200	60,000 New	60,000 $608,000
Q2 2022 Aug 15, 2022	SELL	$8.41 - $10.34 $267,438 - $328,812	-31,800 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$8.33 - $12.96 $264,894 - $412,128	31,800 New	31,800 $304,000
Q4 2020 Feb 16, 2021	SELL	$14.89 - $20.16 $65,516 - $88,704	-4,400 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$14.79 - $22.49 $29,831 - $45,362	-2,017 Reduced 31.43%	4,400 $65,000
Q2 2020 Aug 14, 2020	BUY	$20.64 - $30.69 $132,446 - $196,937	6,417 New	6,417 $135,000
Q3 2019 Nov 14, 2019	SELL	$16.51 - $23.78 $1.32 Million - $1.9 Million	-80,000 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$15.6 - $25.15 $1.05 Million - $1.7 Million	67,500 Added 540.0%	80,000 $1.31 Million
Q1 2019 May 14, 2019	BUY	$22.57 - $28.15 $282,125 - $351,875	12,500 New	12,500 $284,000

122

47.3M

200

12.8K

Ticker TBPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,782,400
Market Cap $640M
Description
Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.